Health Business Community

Advocacy around payment reforms to sustain practices

Advocacy around payment reforms to sustain practices

Payment Reform & Physician Advocacy

Advocacy and Policy Momentum Drive Payment Reforms to Sustain Physician Practices and Ensure Patient Access

Amid ongoing financial pressures and evolving healthcare delivery models, the push for meaningful payment reforms has gained unprecedented momentum. Recent legislative actions, federal policy updates, and innovative state-level strategies underscore a decisive shift toward creating a more sustainable, equitable, and patient-centered reimbursement landscape. These developments are critical to preserving the viability of physician practices—especially small and rural providers—and maintaining broad access to high-quality care.

Continued Advocacy Efforts to Preserve Practice Viability

The American Medical Association (AMA) remains a central advocate in this movement, emphasizing that current payment structures often fail to adequately reflect the complexity, resource investment, and expertise involved in patient care. Their persistent messaging highlights that without reform, many practices—particularly those serving vulnerable populations—face closures and service reductions.

The AMA’s strategic priorities include:

  • Influencing federal and state policymakers to adopt fairer, more accurate payment models
  • Supporting practice resilience through reforms that recognize the true costs of delivering care
  • Ensuring quality and value-based initiatives do not inadvertently penalize providers or exacerbate financial strain

By championing these goals, the AMA aims to foster a healthcare system where providers are fairly remunerated, thus safeguarding patient access and continuity of care.

Recent Policy and Payer Developments Impacting Payment Models

Medicare Advantage Medical Policy Update (March 2026)

In March 2026, CMS released a Medical Policy Update Bulletin signaling significant adjustments to how services are valued and reimbursed within Medicare Advantage (MA) plans. While specifics are still being integrated, the update indicates a shift that could influence provider revenue streams, especially as MA plans cover an increasing proportion of Medicare beneficiaries. This move reflects CMS’s broader efforts to refine value-based payments and improve alignment with care quality metrics.

Extension of CMS Hospital-at-Home Waiver (February 27, 2026)

A landmark achievement was the five-year extension of the CMS hospital-at-home waiver, announced on February 27, 2026. This initiative allows eligible patients to receive hospital-level acute care at home, offering multiple benefits:

  • Enhanced access for underserved and rural communities
  • Reduced hospital burden and capacity constraints
  • Potential for better patient outcomes and satisfaction

Reimbursement models are evolving to accommodate these non-traditional settings, prompting payers to develop new strategies that recognize and support this innovative care delivery approach. The extension signifies a broader move toward value-based, patient-centric models that can improve practice sustainability and health equity.

State-Level Use of Insurer Price Transparency Data

States are increasingly leveraging healthcare price transparency data provided by insurers to inform policy debates and negotiation strategies. Analyses reveal that high and variable healthcare prices contribute significantly to financial strain on providers. Accordingly, states are exploring:

  • Negotiations with payers based on actual practice costs
  • Policy adjustments to foster affordability and fairness
  • Innovative payment models aligned with real-world expenses

This data-driven approach aims to create a more equitable reimbursement environment, reducing financial pressures on practices while ensuring payments reflect true costs of care.

Emerging Policy Debates and Market Dynamics

Beyond federal and state reforms, new discussions are emerging around the roles of intermediaries such as Pharmacy Benefit Managers (PBMs). An illustrative example is the recent op-ed titled "Banning PBMs won’t empower patients in Tennessee," which critiques simplistic proposals to eliminate PBMs. The article emphasizes that such measures may not directly improve patient benefits and could inadvertently disrupt drug affordability and access. It underscores the need for nuanced, comprehensive policies that balance stakeholder interests and recognize the interconnected nature of healthcare supply chains, reimbursement, and patient outcomes.

Additionally, market trends in home healthcare services are expanding, driven by innovations like hospital-at-home programs and increased demand for outpatient care. Resources such as the recent report "Home Healthcare Services Market Growth by Segmentation, Review, Trends, Opportunities, Growth, Demand and Forecast to 2029" highlight the rapid evolution of this sector and its implications for practice sustainability.

Significance of These Developments

Collectively, these policy and legislative updates carry profound implications:

  • Aligning reimbursements with actual care costs ensures the financial health of practices, especially as models shift toward value-based care.
  • Supporting innovative care delivery models, such as hospital-at-home, expands access and reduces traditional hospital burdens.
  • Promoting transparency and utilizing real-world data empower states and providers to craft targeted, effective reforms.
  • Addressing broader market reforms, including PBM regulation and market consolidation, is essential to fostering a balanced, equitable healthcare system.

Next Steps for Advocacy and Policy Engagement

To sustain the momentum, providers and advocacy groups should:

  • Monitor CMS guidance and policy updates closely, engaging with implementation processes.
  • Participate actively in the hospital-at-home expansion, providing feedback to optimize reimbursement strategies.
  • Leverage insurer price data in negotiations and policy proposals to reflect actual practice costs.
  • Engage in debates on market reforms, such as PBM regulation, to influence policies that benefit both providers and patients.
  • Collaborate across stakeholders—including policymakers, payers, patient advocates, and industry partners—to translate reforms into tangible improvements.

Current Status and Implications

As these reforms unfold, the healthcare landscape appears poised for significant transformation. The alignment of advocacy efforts, legislative extensions, and innovative models signals a collective move toward a more sustainable, equitable system. For providers, proactive engagement and strategic adaptation will be critical to thrive amid these changes and continue delivering high-quality, accessible care.

In sum, the evolving policy environment offers both challenges and opportunities. Embracing data-driven reform, supporting innovative delivery models, and participating actively in shaping market reforms will be essential steps for the healthcare community in the coming years.

Sources (8)
Updated Mar 3, 2026